Journal Logo

Poster Session II: Aggressive non-Hodgkin lymphoma – Clinical

PS1074 SANDOZ RITUXIMAB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE PROSPECTIVE NON-INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN-LABEL REFLECT STUDY

Welslau, M.1; Marschner, N.2; Wolff, T.3; Otremba, B.4; Topaly, J.5; da Silva, L. Bittencourt6

Author Information
doi: 10.1097/01.HS9.0000562588.55862.c8
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.